← Back to Search

Device

taVNS for Dyslexia

N/A
Waitlist Available
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
Medications other than those prescribed for ADHD
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks

Summary

This trial will test if a device sending low-level electrical pulses to the ear can help teenagers with dyslexia learn novel letters. It will look at how the brain responds to this device and how the device affects learning.

Who is the study for?
This trial is for adolescents with dyslexia who can read at a certain level (scores above or below 90 on reading measures) and have normal non-verbal IQ. It's not for those with other neurological conditions like autism or epilepsy, nor for those taking medications besides ADHD prescriptions.
What is being tested?
The study tests if taVNS, a low-level nerve stimulation given during letter-learning sessions, helps improve reading skills in dyslexic teens. Participants will receive either real taVNS or sham (fake) treatment to see which is more effective.
What are the potential side effects?
Since this involves low-level nerve stimulation, potential side effects might include discomfort at the site of stimulation. However, as it's a pilot study focused on feasibility and tolerance, detailed side effects are being evaluated.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not on ADHD medication.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adverse events
Compliance
Secondary study objectives
Automaticity
Decoding
Letter ID
Other study objectives
fMRI

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active taVNSExperimental Treatment1 Intervention
Participants will receive custom current at 5 Hz to the left auricular branch of the vagus nerve while learning new letter-sound relationships.
Group II: Sham taVNSPlacebo Group1 Intervention
Participants will undergo current thresholding but device will be turned off without their knowledge during the training.

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,402 Previous Clinical Trials
766,923 Total Patients Enrolled
~67 spots leftby Aug 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top